Onsdag 18 December | 10:41:25 Europe / Stockholm

Bifogade filer

Kalender

Tid*
2025-03-13 13:30 Kvartalsrapport 2025-Q3
2025-01-08 N/A Extra Bolagsstämma 2025
2024-11-28 - Kvartalsrapport 2025-Q2
2024-10-12 - X-dag ordinarie utdelning PHI 0.00 SEK
2024-09-16 - Kvartalsrapport 2025-Q1
2024-06-26 - Bokslutskommuniké 2024
2024-03-27 - Kvartalsrapport 2024-Q3
2023-12-21 - Kvartalsrapport 2024-Q2
2023-11-15 - Extra Bolagsstämma 2024
2023-10-27 - Årsstämma
2023-10-13 - X-dag ordinarie utdelning PHI 0.00 SEK
2023-09-20 - Kvartalsrapport 2024-Q1
2023-06-23 - Bokslutskommuniké 2023
2023-05-09 - Extra Bolagsstämma 2023
2023-03-28 - Kvartalsrapport 2023-Q3
2022-12-21 - Kvartalsrapport 2023-Q2
2022-10-31 - Årsstämma
2022-10-14 - X-dag ordinarie utdelning PHI 0.00 SEK
2022-09-29 - Kvartalsrapport 2023-Q1
2022-06-29 - Bokslutskommuniké 2022
2022-03-21 - Kvartalsrapport 2022-Q3
2022-03-15 - Extra Bolagsstämma 2022
2021-12-29 - Kvartalsrapport 2022-Q2
2021-10-20 - Extra Bolagsstämma 2021
2021-10-11 - X-dag ordinarie utdelning PHI 0.00 SEK
2021-09-29 - Kvartalsrapport 2022-Q1
2021-06-24 - Bokslutskommuniké 2021
2021-03-16 - Kvartalsrapport 2021-Q3
2020-12-14 - Kvartalsrapport 2021-Q2
2020-10-20 - Årsstämma
2020-10-15 - X-dag ordinarie utdelning PHI 0.00 SEK
2020-09-28 - Kvartalsrapport 2021-Q1
2020-06-25 - Bokslutskommuniké 2020
2020-03-12 - Kvartalsrapport 2020-Q3
2019-12-17 - Kvartalsrapport 2020-Q2
2019-10-16 - X-dag ordinarie utdelning PHI 0.00 SEK
2019-10-15 - Årsstämma
2018-09-27 - X-dag ordinarie utdelning PHI 0.00 SEK
2018-09-26 - Årsstämma
2018-06-18 - Extra Bolagsstämma 2019
2018-06-12 - Bokslutskommuniké 2018
2018-03-12 - Kvartalsrapport 2018-Q3
2017-09-26 - X-dag ordinarie utdelning PHI 0.00 SEK
2017-09-25 - Årsstämma
2017-09-11 - Kvartalsrapport 2018-Q1
2017-06-19 - Bokslutskommuniké 2017
2017-03-13 - Kvartalsrapport 2017-Q3
2017-01-01 - Extra Bolagsstämma 2018
2016-11-30 - Kvartalsrapport 2017-Q2
2016-09-06 - X-dag ordinarie utdelning PHI 0.00 SEK
2016-09-05 - Årsstämma
2016-09-05 - Kvartalsrapport 2017-Q1
2016-06-13 - Bokslutskommuniké 2016
2016-02-22 - Kvartalsrapport 2016-Q3
2016-02-16 - Extra Bolagsstämma 2017
2015-11-30 - Kvartalsrapport 2016-Q2
2015-09-08 - X-dag ordinarie utdelning PHI 0.00 SEK
2015-09-07 - Årsstämma
2015-09-07 - Kvartalsrapport 2016-Q1
2015-06-16 - Bokslutskommuniké 2015
2015-03-16 - Kvartalsrapport 2015-Q3
2014-12-01 - Kvartalsrapport 2015-Q2
2014-10-07 - X-dag ordinarie utdelning PHI 0.00 SEK
2014-10-06 - Årsstämma
2014-10-06 - Kvartalsrapport 2015-Q1
2014-06-30 - Bokslutskommuniké 2014

Beskrivning

LandSverige
ListaSpotlight
SektorHälsovård
IndustriMedicinteknik
PHI är verksamt inom medicinteknik och utvecklar både hårdvara och mjukvara för kvantitativ analys av levande cellkulturer. Produkterna HoloMonitor® bygger på icke-invasiv QPI-teknologi som insamlar data om cellkvalitet och säljs global via distributörer med fokus på preklinisk cancerforskning, stamcellerforskning och läkemedelsutveckling. Framöver fokuserar PHI på att utveckla sina produkter till den kliniska marknaden och inom regenerativ medicin. PHI har kontor i Lund, Boston, och Winston-Salem.
2024-12-02 08:40:12

Phase Holographic Imaging PHI AB ("PHI" or the "Company") today announces that the Company's global distributor Altium SA ("Altium") has placed an order of HoloMonitor® systems and add-ons to a total value of approximately EUR 460 K. The total expected order value from Altium for the full fiscal year of 2024/2025 is estimated to amount to approximately EUR 2 million.

Order from Altium

The order placed by Altium, amounting to a total value of approximately EUR 460 K, is expected to be shipped in December 2024, meaning that this is assessed to be recognized in the Company's Q3-report for the fiscal year 2024/2025. The order is a part of the existing distribution agreement that PHI and Altium entered into in November 2023 and is within the frames of the order agreement regarding 20 HoloMonitor® systems that was communicated in September 2024. Altium has a wide network around the globe and thus potential to broaden the market access for PHI's products extensively. Over the last year, Altium has subcontracted various resellers and opened up many new markets for PHI.

Sales outlook for PHI

PHI's fiscal year runs from 1 May until 30 April, resulting in a third quarter stemming from November through January and a fourth quarter from February through April. Given the distribution agreement with Altium, PHI and Altium have spent the first two quarters of the fiscal year 2024/2025 focusing on doing the groundwork and laying a foundation of the collaboration, as well as training and supporting the subcontractors of Altium. Whereas sales numbers have taken a small hit in the first two quarters this fiscal year, PHI expects for the laid work and extensive collaboration to yield improved results and show significant achievements in the quarters ahead, securing long-term growth. The orders now placed by Altium will contribute to a strong third quarter, and the total expected order value from Altium for the full fiscal year of 2024/2025 is estimated to amount to approximately EUR 2 million.

Goran Dubravčić, Chairman of PHI and CEO of Altium, comments

"Altium experiences a high demand for PHI's products, and with our knowledge and experience of the market for these types of products, we expect this order flow to continue going forward. The further upgraded versions of the HoloMonitor® in the coming years will, in our view, open up even more possibilities and attract more interest, leading to further business."

Anders Månsson, CEO of PHI, comments

"PHI has, in the first and second quarter of 2024/2025, spent the majority of time focusing on establishing the collaboration between PHI and Altium and educating Altium's sales personnel and subcontractors in the HoloMonitor® systems. With the orders made by Altium, totalling a significant value, we can start to see the work put in paying off, and this is what we expect in future quarters as well."

This disclosure contains information that Phase Holographic is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 02-12-2024 08:40 CET.